Location History:
- Setagaya, JP (1995)
- Okazaki, JP (1992 - 1999)
- Kariya, JP (1997 - 1999)
- Okazaki, Aichi, JP (2001)
Company Filing History:
7 out of 4,455 
1 out of 832,880 Years Active: 1992-2001
Certainly! Here is the article about inventor Kaoru Shimada:
Title: The Innovative Work of Inventor Kaoru Shimada
Introduction: Kaoru Shimada, a talented inventor based in Okazaki, Japan, has made significant contributions to the field of pharmaceutical research and drug metabolism assessment. With a total of 8 patents to his name, Shimada's groundbreaking inventions have revolutionized the way drug metabolism is evaluated in the industry.
Latest Patents:
1. Quinuclidine derivatives - Compounds of the formula
2. Method for evaluating drug metabolism and reagent compositions therefor
Career Highlights: Shimada's latest patent involves a method for assessing the susceptibility of pharmaceutical drugs to metabolism by specific cytochrome P-450 isozymes. This innovative approach includes utilizing a reagent composition that allows for in vitro quantitative assays for drug metabolism by P-450 isozymes such as CYP2D6, CYP2C19, and CYP2A6. His work has paved the way for more efficient drug development processes and improved pharmaceutical research methodologies.
Collaborations: Throughout his esteemed career, Shimada has collaborated with reputable organizations such as Pfizer Corporation, where he has had the opportunity to work alongside esteemed colleagues like Fumitaka Ito and Masami Nakane. These partnerships have further amplified the impact of Shimada's inventions and have led to significant advancements in the pharmaceutical industry.
Conclusion: In conclusion, Kaoru Shimada's relentless dedication to innovation and his pioneering work in pharmaceutical research have solidified his position as a distinguished inventor in the field. His patents and collaborations stand as a testament to his unwavering commitment to driving progress and excellence in drug metabolism evaluation.